Jaguar Health, Inc. (NASDAQ:JAGX) | WebDisclosure

Switch to English

10441	Sociétés
219100	Mots-clés
148536	Articles
115882	Communiqués

Accueil
Sociétés
Jaguar Health, Inc.

COMMUNIQUÉ DE PRESSE

publié le 04/09/2024 à 16:00, il y a 1 année 8 mois

New Innovators with Jane King Interview with Jaguar Health CEO Lisa Conte Spotlights Company’s Near-Term Commercial & Development Milestones
Jaguar Health, Inc. announces near-term activities including Gelclair launch and crofelemer trials for rare diseases. Includes Lisa Conte interview details

Jaguar Health Inc. Rare Diseases Gelclair Launch Crofelemer Trials Lisa Conte Interview
BRÈVE

publiée le 27/08/2024 à 16:05, il y a 1 année 8 mois

Patent Issued in Jordan Bolsters IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS)

Crofelemer Short Bowel Syndrome Patent Jaguar Health Intellectual Property
BRÈVE

publiée le 27/08/2024 à 16:05, il y a 1 année 8 mois

Un brevet délivré en Jordanie renforce la protection de la propriété intellectuelle de Jaguar Health dans le traitement du syndrome de l'intestin court (SIC)

Crofelemer Propriété Intellectuelle Brevet Santé Jaguar Syndrome De L'intestin Court
COMMUNIQUÉ DE PRESSE

publié le 27/08/2024 à 16:00, il y a 1 année 8 mois

Patent Issued in Jordan Bolsters IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS)
Jaguar Health, Inc. announces issuance of new patent for crofelemer to treat rare diseases like SBS and MVID, enhancing IP protection. Independent studies supported in US, EU, and MENA regions

Crofelemer Patent Jaguar Health Rare Diseases SBS
BRÈVE

publiée le 20/08/2024 à 16:05, il y a 1 année 9 mois

Key Collaborator of Jaguar Health Joint Venture Magdalena Biosciences Receives Prestigious Alzheimer's Association Award

Jaguar Health Magdalena Biosciences Alzheimer's Award Eduardo Zimmer Botanical Drugs
BRÈVE

publiée le 20/08/2024 à 16:05, il y a 1 année 9 mois

Magdalena Biosciences, collaboratrice clé de la joint-venture Jaguar Health, reçoit le prestigieux prix de l'Alzheimer's Association

Santé Jaguar Eduardo Zimmer Biosciences De Magdalena Prix Alzheimer Médicaments À Base De Plantes
COMMUNIQUÉ DE PRESSE

publié le 20/08/2024 à 16:00, il y a 1 année 9 mois

Key Collaborator of Jaguar Health Joint Venture Magdalena Biosciences Receives Prestigious Alzheimer's Association Award
Jaguar Health announces Eduardo Zimmer as 2024 Blas Frangione Early Career Achievement Award recipient for work with Magdalena Biosciences on plant-based mental health medicines

Mental Health Jaguar Health Magdalena Biosciences Plant-based Medicines Eduardo Zimmer
BRÈVE

publiée le 12/08/2024 à 16:05, il y a 1 année 9 mois

Jaguar Health to Host Investor Webcast on August 13th

Crofelemer Investor Webcast Cancer Therapy-related Diarrhea Phase 3 Trial Q2 Financials
BRÈVE

publiée le 12/08/2024 à 16:05, il y a 1 année 9 mois

Jaguar Health organise un webcast pour les investisseurs le 13 août

Crofelemer Essai De Phase 3 Résultats Financiers Du Deuxième Trimestre Webcast Pour Les Investisseurs Diarrhée Liée Au Traitement Du Cancer
COMMUNIQUÉ DE PRESSE

publié le 12/08/2024 à 16:00, il y a 1 année 9 mois

REMINDER: Jaguar Health to Hold Investor Webcast Tuesday, August 13th at 8:30 AM Eastern to Review Q2 Earnings and Further Review Phase 3 OnTarget Trial’s Clinically Meaningful Results in Breast and Lung Cancer Patients
Jaguar Health plans crofelemer approval pathway for breast and lung cancer based on phase 3 results. Join the investor webcast on August 13, 2024, for financial & corporate updates

Crofelemer Investor Webcast FDA Approval Jaguar Health Phase 3 Results

Les Echos

Publié le 22/05/2026 à 08:30, il y a 1 heure 27 minutes

Eiffage is building four solar power plants for the NOOR Atlas programme in Morocco
Publié le 22/05/2026 à 08:30, il y a 1 heure 27 minutes

Eiffage réalise quatre centrales photovoltaïques dans le cadre du programme NOOR Atlas au Maroc
Publié le 21/05/2026 à 17:50, il y a 16 heures 7 minutes

CDA - H1 results 2025 2026
Publié le 21/05/2026 à 17:45, il y a 16 heures 12 minutes

CEGEDIM: DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Publié le 21/05/2026 à 17:45, il y a 16 heures 12 minutes

CEGEDIM: DECLARATION D’ACTIONS ET DE DROITS DE VOTE

Voir tout LES ECHOS COMFI WIRE

Accesswire

Publié le 22/05/2026 à 08:00, il y a 1 heure 57 minutes

Caledonia Mining Corporation Plc: Refiling of Bilboes Gold Project Feasibility Study National Instrument 43-101 Technical Report
Publié le 22/05/2026 à 00:45, il y a 9 heures 12 minutes

Credissential Announces Private Placement
Publié le 21/05/2026 à 23:00, il y a 10 heures 57 minutes

Silver Wolf Adopts Semi-Annual Financial Reporting
Publié le 21/05/2026 à 23:00, il y a 10 heures 57 minutes

Medicure Reports Financial Results for Quarter Ended March 31, 2026 and Schedules May 25, 2026 Conference Call
Publié le 21/05/2026 à 23:00, il y a 10 heures 57 minutes

Revival Gold Announces Adoption of Shareholder Rights Plan and Corporate Update

Voir tout ACCESSWIRE

EQS Group

Publié le 22/05/2026 à 09:12, il y a 45 minutes

Aroundtown SA announces publication of convening notice for the 2026 Annual General Meeting
Publié le 22/05/2026 à 09:11, il y a 46 minutes

Grand City Properties S.A. announces publication of convening notice for the 2026 Annual General Meeting
Publié le 22/05/2026 à 09:11, il y a 46 minutes

Aroundtown SA announces publication of convening notice for the 2026 Annual General Meeting
Publié le 22/05/2026 à 09:10, il y a 47 minutes

Grand City Properties S.A. announces publication of convening notice for the 2026 Annual General Meeting
Publié le 22/05/2026 à 09:02, il y a 55 minutes

Viromed Medical AG significantly increases consolidated revenue in the 2025 financial year and achieves a positive net income